1-1 of 1
Andrew Leishman, PhD
Close
Sort by
Journal Articles

CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML

Kristopher Clark, PhD, Edward Ainscow, PhD, Adam Peall, Stuart Thomson, PhD, Andrew Leishman, PhD, Sullivan Elaine, PhD, Simak Ali, PhD, Raoul Coombes, MD, Anthony Barrett, PhD, Ash Kumar Bahl, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2645.
https://doi.org/10.1182/blood.V130.Suppl_1.2645.2645
Published: 2017